Company intelligence / Profile preview

NanoSanguis

Warsaw, Poland
Ownership
Private
Employees
~20
Development stage
Other
01

Overview

NanoSanguis is a Polish biotechnology company specializing in the development of synthetic oxygen carriers and advanced organ preservation systems. As a subsidiary of NanoGroup S.A., the company utilizes proprietary nanotechnology to develop 'artificial blood' (NanoRed) that mimics the oxygen-carrying capacity of red blood cells while offering a longer shelf life and universal compatibility. Their portfolio also includes NanoPreserve, a solution designed to extend the viability of organs during transport for transplantation. NanoSanguis focuses on addressing critical gaps in transfusion medicine and transplantology through innovative nanomedicine solutions. The company is a spin-off from the Warsaw University of Technology and maintains strong ties with academic research to drive its product development.

Therapeutic areas
HematologyCardiovascularImmunology
Modalities
NanoparticleSynthetic oxygen carrier
Industry
Biotech
02

Partnerships

Warsaw University of Technology

Beyond the preview

Go deeper on NanoSanguis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NanoSanguis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call